Aclaris: Q4 Earnings Snapshot
Aclaris Therapeutics Inc. (ACRS) on Thursday reported a loss of $27.6 million in its fourth quarter
By AP News
Published - Feb 23, 2023, 07:33 AM ET
Last Updated - Apr 30, 2024, 11:48 PM EDT
WAYNE, Pa. (AP) — WAYNE, Pa. (AP) — Aclaris Therapeutics Inc. (ACRS) on Thursday reported a loss of $27.6 million in its fourth quarter.
The Wayne, Pennsylvania-based company said it had a loss of 41 cents per share.
The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 46 cents per share.
The specialty pharmaceutical company posted revenue of $7.8 million in the period, which also beat Street forecasts. Six analysts surveyed by Zacks expected $2.2 million.
